NCT00275093View on ClinicalTrials.gov

Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2008

Conditions
Hepatic ComplicationsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

temsirolimus

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

78229

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00275093 - Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function | Biotech Hunter | Biotech Hunter